Malladi Drugs & Pharmaceuticals, Ltd. v. Tandy

538 F. Supp. 2d 162, 2008 U.S. Dist. LEXIS 19119, 2008 WL 678588
CourtDistrict Court, District of Columbia
DecidedMarch 13, 2008
DocketCivil Action No. 07-4069 (RMC)
StatusPublished
Cited by3 cases

This text of 538 F. Supp. 2d 162 (Malladi Drugs & Pharmaceuticals, Ltd. v. Tandy) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Malladi Drugs & Pharmaceuticals, Ltd. v. Tandy, 538 F. Supp. 2d 162, 2008 U.S. Dist. LEXIS 19119, 2008 WL 678588 (D.D.C. 2008).

Opinion

MEMORANDUM OPINION

ROSEMARY M. COLLYER, District Judge.

The Drug Enforcement Administration (“DEA”) has quite a problem. It routinely seizes controlled substances, such as chemicals for manufacturing pharmaceuticals, when an imported shipment does not comply with the stringent regulatory scheme. An interested party can file a “claim” and require DEA to seek judicial forfeiture of any seizure worth less than $500,000. See 18 U.S.C. § 983(a)(2) & (3); compare 19 U.S.C. § 1607(a)(1) (goods valued at less than $500,000 maybe forfeited administratively). 1 Or an interested party can file a “petition” to ask the Administrator of DEA, Defendant Karen Tandy, to give the chemicals back as a matter of executive discretion. See 21 C.F.R. § 1316.80; see also 28 C.F.R. § 9.5. Both a “claim” and a “petition” basically require the same information and, although forms are available, forms are not required. How, then, is the *164 DEA to know whether it is dealing with a claimant entitled to a judicial hearing or a petitioner who is not? In this case, the Plaintiffs filed multiple Petitions for Remission or Mitigation of Forfeiture after DEA seized certain chemicals because of regulatory improprieties. DEA denied all petitions and denied requests for reconsideration and administratively forfeited the chemicals. Plaintiffs now bring suit, asserting that DEA should have treated their papers as both “petitions” and “claims” and ensured that they received a hearing before a federal judge prior to forfeiture.

I. BACKGROUND FACTS

Malladi Drugs & Pharmaceuticals, Ltd. (“Malladi DPL”) is a supplier of pharmaceutical raw materials based in India. Pl.’s First Am. Compl. (“Am. Compl.”) ¶¶2, 8. Plaintiff NOVUS Fine Chemicals, L.L.C. (“Novus”) is a United States corporation based in New Jersey and is a wholly owned subsidiary of Malladi DPL. Am. Compl. ¶2. Non-party Malladi, Inc., is a now-dormant subsidiary of Malladi DPL, formerly located in New Jersey. Id. ¶¶ 7, 14, 17. At the relevant time period in 2005, Malladi, Inc., was in the business of importing List 1 Chemicals from Malladi DPL and selling them in this country to, among others, Novus. Id. ¶¶ 13-15.

List 1 Chemicals are chemicals that are used in the manufacture of controlled substances. 21 U.S.C. § 802(34). Controlled substances, in general, are either illegal drugs or drugs that may be obtained only with a prescription. 2 To prevent the diversion of List I Chemicals to the illicit manufacture of controlled substances, these chemicals may be imported and possessed only by persons or entities with a valid DEA registration. 21 U.S.C. § 822; 21 C.F.R. § 1309.21. Once imported, List I Chemicals are subject to detailed reporting requirements to ensure that they are used solely for legitimate purposes. 21 C.F.R. Pt. 1304. DEA has the right to seize “[a]ll listed chemicals ... which have been imported, ... possessed, ... acquired, or intended to be ... acquired, [or] imported ... in violation of’ these laws and regulations. 21 U.S.C. § 888(a)(9).

On April 6, 2005, DEA agents inspected Malladi, Inc.’s administrative procedures for keeping track of List 1 Chemicals ephedrine, psuedoephedrine, ephedrine hydrochloride and psuedoephedrine hydrochloride (“the Chemicals”). See Am. Compl. ¶ 14. The agents “expressed reservations about the organization of Malladi Inc.’s file room, its document retention system and the availability of documentation necessary to reconcile inventory.” Id. ¶ 14. 3 On April 8, 2005, DEA agents re *165 turned to Malladi, Inc., and seized 233 drums of the Chemicals valued at $241,500; these Chemicals were being held as inventory at corporate headquarters in Edison, New Jersey. Id. ¶ 17. Three days later, on April 11, 2005, “in a good faith effort to display cooperation that the DEA officials stated would be helpful, [Malladi Inc.] surrendered [its] import registration. Id. ¶ 19. As a result, Malladi [Inc.] [was and is] no long able to possess List I Chemicals.” Id., Ex. 4 at 3.

Unfortunately for Malladi DPL, it had three inbound shipments of the Chemicals that it had exported from India and shipped to Malladi, Inc., although the subsidiary corporation no longer had a right to receive or possess them. See Am. Compl. ¶¶ 20-22. On April 14, 2005, DEA seized 400 drums of Chemicals upon their arrival at the Port of Newark, New Jersey. Id. ¶ 20. This seizure was valued at $464,000. Id. A third seizure occurred on April 27, when DEA seized 240 drums of Chemicals upon their arrival at the Port of Staten Island, New York. Id. ¶ 21. This seizure was valued at $250,500. Id. Lastly, DEA seized 400 drums of Chemicals when they arrived at the Port of Elizabeth, New Jersey, on May 2, 2005. Id. ¶22. This final seizure was valued at $464,000. Id. The aggregate value of all four seizures is $1,420,000. Id. ¶ 26.

The Plaintiffs received timely notice of each of the seizures and responded to DEA seeking their return. See Am. Compl., Exs. 1-4. On May 20, 2005, Novus filed a Petition for Remission or Mitigation of Forfeiture challenging the April 14 seizure at the Port of Newark and the May 2 seizure at the Port of Elizabeth. Id., Exs. 2a & 2b. Two months later, on July 12, Malladi DPL filed a separate Petition for Remission or Mitigation challenging the Staten Island seizure that had occurred on Aril 27. Id., Ex. 3. Finally, on October 21, 2005, Malladi DPL filed a Petition for Remission or Mitigation seeking the return of the inventory seized on April 8, 2005, from Malladi, Inc.’s corporate headquarters. Id., Ex. 4. Each of the Petitions was filed with the assistance of and by legal counsel. Id. ¶¶ 44-46. DEA forfeited all four seizures administratively and denied the Petitions and motions for reconsideration.

II. STATUTORY BACKGROUND

Civil forfeiture of inanimate objects used in criminal schemes has long been prevalent in the United States. It has its origins in the common law.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Brown v. Government of the District of Columbia
115 F. Supp. 3d 56 (District of Columbia, 2015)
Martin v. Leonhart
717 F. Supp. 2d 92 (District of Columbia, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
538 F. Supp. 2d 162, 2008 U.S. Dist. LEXIS 19119, 2008 WL 678588, Counsel Stack Legal Research, https://law.counselstack.com/opinion/malladi-drugs-pharmaceuticals-ltd-v-tandy-dcd-2008.